Learn medical monitoring and AI-assisted safety oversight the way the real-time era of clinical trials demands — the IHASG approach, from the people defining the standard.
Free to join the interest list · No commitment · Be first to hear when cohorts open
The shift to AI-assisted and real-time trials hasn’t reduced the need for human judgment — it has concentrated it. Every algorithmic flag creates a matching obligation: a qualified person must adjudicate benefit-risk and document it to an inspection-ready standard. That work is growing fast, it is least substitutable in high-acuity oncology and cell therapy, and remarkably few people are being trained to do it well.
If you want a clinical-safety career that the next decade rewards, this is the direction it is heading.
Integrated High-Acuity Safety Governance — a documented, defensible method for adjudicating AI-flagged signals, not a generic pharmacovigilance overview.
CAR-T and CGT toxicities that escalate in hours — CRS, ICANS, and the acute windows where judgment matters most and software stops.
Learn from a physician who has led safety across 100+ oncology trials and the architect of a platform that powered 1,000+ — not staffed down.
Drug safety associates, PV scientists, and safety nurses ready to upskill into novel-therapy and AI-assisted oversight.
Clinicians who want to add medical-monitoring and high-acuity safety credentials — and a new way to apply them.
Clinical ops, data, and regulatory people who want to understand where safety judgment fits in real-time trials.
Late-stage trainees and career-changers who want a credible, modern on-ramp into clinical safety.
A structured way to learn medical monitoring and AI-assisted safety oversight — from fundamentals to high-acuity novel-therapy case handling.
The opportunity to work toward IHASG Practitioner recognition — a credential built to mean something because it is hard to earn.
A community of credentialed reviewers and peers working at the front edge of clinical safety.
The strongest graduates may be invited into our expert network — and considered for oversight and placement opportunities as they arise. (An opportunity, not a guarantee.)
Tell us a little about you and we’ll send details on the programmes, cohort dates, and the credential pathway as they’re announced. And follow us on LinkedIn — that’s where it all gets shared first.
The field needs more people who can do this work well. Share this with a colleague who’d want to learn it.